226. Antimicrobial Novel Agents: Saturday, 12:15 - 1:30 p.m.
Poster Session: Antimicrobial Novel Agents
Jon Bruss, M.D.
Spero Therapeutics
Cambridge, Massachusetts, United States
Justin C. Bader, PharmD
Spero Therapeutics, Inc.
Cambridge, Massachusetts, United States
Kamal Hamed, MD, MPH
Chief Medical Officer
Spero Therapeutics, Inc.
Cambridge, Massachusetts, United States